SEC Form 4 · accession 0001255294-15-000238
Rich Pharmaceuticals, Inc. · RCHA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ben Chang
Officer — CEO, CFO, Pres · Director · 10% Owner
Period of report
Apr 6, 2015
Accepted (ET)
Apr 8, 2015 · 5:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504389
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $0.0008 | Apr 6, 2015 | A | 50,000,000 | A | Apr 6, 2015 | Apr 6, 2020 | Common Stock | 50,000,000 | 53,246,000 | D |
Explanation of responses
- F1The Reporting Person was granted options to purchase under the Rich Pharmaceuticals, Inc. 2013 Stock Option/Stock Issuance Plan. The stock options are immediately vested and may be exercised by cashless exercise.